{{Rsnum
|rsid=1160542
|Gene=LOC150577
|Chromosome=2
|position=100215693
|Orientation=plus
|GMAF=0.4522
|Gene_s=ADSSL1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 31.2 | 53.6 | 15.2
| HCB | 37.2 | 47.4 | 15.3
| JPT | 31.9 | 46.0 | 22.1
| YRI | 5.5 | 32.4 | 62.1
| ASW | 7.0 | 36.8 | 56.1
| CHB | 37.2 | 47.4 | 15.3
| CHD | 37.6 | 50.5 | 11.9
| GIH | 18.8 | 49.5 | 31.7
| LWK | 5.5 | 26.4 | 68.2
| MEX | 10.5 | 56.1 | 33.3
| MKK | 4.5 | 34.6 | 60.9
| TSI | 32.4 | 48.0 | 19.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=20498205
|Title=Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markers
|OA=1
}}

{{PMID Auto
|PMID=19359276
|Title=Identification of AF4/FMR2 family, member 3 (AFF3) as a novel rheumatoid arthritis susceptibility locus and confirmation of two further pan-autoimmune susceptibility genes.
|OA=1
}}

{{PMID Auto
|PMID=20072139
|Title=Association of the AFF3 gene and IL2/IL21 gene region with juvenile idiopathic arthritis.
|OA=1
}}

{{PMID Auto
|PMID=20444755
|Title=Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment.
|OA=1
}}

{{PMID Auto
|PMID=22328738
|Title=Comprehensive assessment of rheumatoid arthritis susceptibility loci in a large psoriatic arthritis cohort.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}